Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 17/20 | 0.71 |
| ▸ | EGFR | P00533 | 16/20 | 0.71 |
| ▸ | PDGFRB | P09619 | 14/20 | 0.71 |
| ▸ | PDGFRA | P16234 | 10/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13276054 | 0.83 | KDR (0.68) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL3124173 | 0.83 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17858425 | 0.80 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837008 | 0.80 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837022 | 0.79 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837015 | 0.78 | KDR (0.82) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837005 | 0.78 | KDR (1.00) | KDREGFRPDGFRBPDGFRAKDM4E | |
| SCHEMBL17837014 | 0.78 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837028 | 0.75 | KDR (1.00) | KDREGFRPDGFRBPDGFRA | |
| SCHEMBL17837012 | 0.74 | PDGFRB (1.00) | KDREGFRPDGFRBPDGFRAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200290976-A1 | RADIOLABELED MICROTUBULE IMAGING COMPOUNDS AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2020-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200290976-A1 | RADIOLABELED MICROTUBULE IMAGING COMPOUNDS AND USES THEREOF | TUBB3, MAP2, MAPT | KDR 1248/4885EGFR 1574/4885PDGFRB 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.